Brihad Abhyankar
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
A Phase 2 Study of MORF-057, an Oral α4β7 Integrin Inhibitor in Moderately to Severely Active Ulcerative Colitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 26, 2024
Development of Gut-Selective Pan-Janus Kinase Inhibitor TD-1473 for Ulcerative Colitis: A Translational Medicine Programme.
Journal: Journal of Crohn's & colitis
Published: March 13, 2020
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Journal: The New England journal of medicine
Published: September 26, 2019
Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease-authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: July 13, 2018
Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: April 04, 2017
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy.
Journal: Inflammatory bowel diseases
Published: December 09, 2016
Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease.
Journal: Alimentary pharmacology & therapeutics
Published: September 30, 2016
Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease Patients Stratified by Age.
Journal: Advances in therapy
Published: September 16, 2016
Long-term Efficacy of Vedolizumab for Crohn's Disease.
Journal: Journal of Crohn's & colitis
Published: June 24, 2016
Long-term Efficacy of Vedolizumab for Ulcerative Colitis.
Journal: Journal of Crohn's & colitis
Published: June 24, 2016
An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab.
Journal: Journal of Crohn's & colitis
Published: June 03, 2016
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: May 18, 2016
Last Updated: 09/26/2026